These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27144172)

  • 1. Cancerous Inhibitor of PP2A Silencing Inhibits Proliferation and Promotes Apoptosis in Human Multiple Myeloma Cells.
    Yang X; Zhang Y; Liu H; Lin Z
    Biomed Res Int; 2016; 2016():6864135. PubMed ID: 27144172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CIP2A regulates proliferation and apoptosis of multiple myeloma cells.
    Zheng Z; Qiao Z; Chen W; Gong R; Wang Y; Xu L; Ma Y; Zhang L; Lu Y; Jiang B; Li G; Dong C
    Mol Med Rep; 2016 Sep; 14(3):2705-9. PubMed ID: 27484817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p90/CIP2A mediates breast cancer cell proliferation and apoptosis.
    Liu X; Peng B; Li Y; Lei N; Li W; Zhang JY
    Mol Biol Rep; 2014 Nov; 41(11):7471-8. PubMed ID: 25086622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells.
    Chen KF; Liu CY; Lin YC; Yu HC; Liu TH; Hou DR; Chen PJ; Cheng AL
    Oncogene; 2010 Nov; 29(47):6257-66. PubMed ID: 20729919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arctigenin inhibits triple-negative breast cancers by targeting CIP2A to reactivate protein phosphatase 2A.
    Huang Q; Qin S; Yuan X; Zhang L; Ji J; Liu X; Ma W; Zhang Y; Liu P; Sun Z; Zhang J; Liu Y
    Oncol Rep; 2017 Jul; 38(1):598-606. PubMed ID: 28560452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genistein targets the cancerous inhibitor of PP2A to induce growth inhibition and apoptosis in breast cancer cells.
    Zhao Q; Zhao M; Parris AB; Xing Y; Yang X
    Int J Oncol; 2016 Sep; 49(3):1203-10. PubMed ID: 27574003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of CIP2A determines erlotinib-induced apoptosis in hepatocellular carcinoma.
    Yu HC; Chen HJ; Chang YL; Liu CY; Shiau CW; Cheng AL; Chen KF
    Biochem Pharmacol; 2013 Feb; 85(3):356-66. PubMed ID: 23178652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression.
    Liu CY; Huang TT; Chen YT; Chen JL; Chu PY; Huang CT; Wang WL; Lau KY; Dai MS; Shiau CW; Tseng LM
    EBioMedicine; 2019 Feb; 40():263-275. PubMed ID: 30651219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CIP2A regulates cell proliferation via the AKT signaling pathway in human lung cancer.
    Lei N; Peng B; Zhang JY
    Oncol Rep; 2014 Oct; 32(4):1689-94. PubMed ID: 25109354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FL118 inhibits viability and induces apoptosis of colorectal cancer cells via inactivating the CIP2A/PP2A axis.
    Lin X; Gao M; Zhang A; Tong J; Zhang X; Su Q; Yang Z; Gao H; Jiang G
    Life Sci; 2019 Dec; 239():117074. PubMed ID: 31751585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CIP2A, an oncoprotein, is associated with cell proliferation, invasion and migration in laryngeal carcinoma cells.
    Chen XD; Tang SX; Zhang JH; Zhang LT; Wang YW
    Oncol Rep; 2017 Aug; 38(2):1005-1012. PubMed ID: 28656258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CIP2A depletion potentiates the chemosensitivity of cisplatin by inducing increased apoptosis in bladder cancer cells.
    Gao F; Wang X; Chen S; Xu T; Wang X; Shen Y; Dong F; Zhong S; Shen Z
    Oncol Rep; 2018 Nov; 40(5):2445-2454. PubMed ID: 30106121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CIP2A mediates erlotinib-induced apoptosis in non-small cell lung cancer cells without EGFR mutation.
    Wang CY; Chao TT; Chang FY; Chen YL; Tsai YT; Lin HI; Huang YC; Shiau CW; Yu CJ; Chen KF
    Lung Cancer; 2014 Aug; 85(2):152-60. PubMed ID: 24954871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cucurbitacin B induces autophagy and apoptosis by suppressing CIP2A/PP2A/mTORC1 signaling axis in human cisplatin resistant gastric cancer cells.
    Liu X; Duan C; Ji J; Zhang T; Yuan X; Zhang Y; Ma W; Yang J; Yang L; Jiang Z; Yu H; Liu Y
    Oncol Rep; 2017 Jul; 38(1):271-278. PubMed ID: 28534965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CIP2A inhibits PP2A in human malignancies.
    Junttila MR; Puustinen P; Niemelä M; Ahola R; Arnold H; Böttzauw T; Ala-aho R; Nielsen C; Ivaska J; Taya Y; Lu SL; Lin S; Chan EK; Wang XJ; Grènman R; Kast J; Kallunki T; Sears R; Kähäri VM; Westermarck J
    Cell; 2007 Jul; 130(1):51-62. PubMed ID: 17632056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cucurbitacin B reverses multidrug resistance by targeting CIP2A to reactivate protein phosphatase 2A in MCF-7/adriamycin cells.
    Cai F; Zhang L; Xiao X; Duan C; Huang Q; Fan C; Li J; Liu X; Li S; Liu Y
    Oncol Rep; 2016 Aug; 36(2):1180-6. PubMed ID: 27350399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CIP2A mediates fibronectin-induced bladder cancer cell proliferation by stabilizing β-catenin.
    Gao F; Xu T; Wang X; Zhong S; Chen S; Zhang M; Zhang X; Shen Y; Wang X; Xu C; Shen Z
    J Exp Clin Cancer Res; 2017 May; 36(1):70. PubMed ID: 28521777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CIP2A overexpression induces autoimmune response and enhances JNK signaling pathway in human lung cancer.
    Peng B; Chai Y; Li Y; Liu X; Zhang J
    BMC Cancer; 2015 Nov; 15():895. PubMed ID: 26560124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancerous inhibitor of protein phosphatase 2A contributes to human papillomavirus oncoprotein E7-induced cell proliferation via E2F1.
    Zhang W; Chen H; Chen Y; Liu J; Wang X; Yu X; Chen JJ; Zhao W
    Oncotarget; 2015 Mar; 6(7):5253-62. PubMed ID: 25650660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypes.
    Niemelä M; Kauko O; Sihto H; Mpindi JP; Nicorici D; Pernilä P; Kallioniemi OP; Joensuu H; Hautaniemi S; Westermarck J
    Oncogene; 2012 Sep; 31(39):4266-78. PubMed ID: 22249265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.